These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

108 related articles for article (PubMed ID: 674697)

  • 1. Burimamide is a selective inhibitor of thromboxane-A biosynthesis in human platelet microsomes.
    Allan G; Eakins KE
    Prostaglandins; 1978 Apr; 15(4):659-61. PubMed ID: 674697
    [No Abstract]   [Full Text] [Related]  

  • 2. Inhibition of thromboxane A2 biosynthesis in human platelets by burimamide.
    Allan G; Eakins KE; Kulkarni PS; Levi R
    Br J Pharmacol; 1980; 71(1):157-64. PubMed ID: 6781572
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The effects of dipyridamole on TXA2 formation by horse platelet microsomes.
    Katano Y; Imai S
    Prostaglandins Leukot Med; 1983 Feb; 10(2):179-85. PubMed ID: 6573686
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Nicotinic acid inhibits thromboxane synthesis in platelets.
    Vincent JE; Zijlstra FJ
    Prostaglandins; 1978 Apr; 15(4):629-36. PubMed ID: 674694
    [No Abstract]   [Full Text] [Related]  

  • 5. [Biosynthesis of prostaglandins and thromboxane in the blood platelets].
    Katori M
    Nihon Rinsho; 1978 Dec; 36(12):3805-12. PubMed ID: 372618
    [No Abstract]   [Full Text] [Related]  

  • 6. Platelet rich plasma transforms exogenous prostaglandin endoperoxide H2 into thromboxane A2.
    Fitzpatrick FA; Gorman RR
    Prostaglandins; 1977 Nov; 14(5):881-9. PubMed ID: 594390
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Platelet aggregation and thromboxane A2 formation in cat platelet rich plasma.
    Marcinkiewicz E; Grodzińska L; Gryglewski RJ
    Pharmacol Res Commun; 1978 Jan; 10(1):1-12. PubMed ID: 643889
    [No Abstract]   [Full Text] [Related]  

  • 8. Enhanced prostacyclin biosynthesis and decreased thromboxane formation by 3-dimethylamino 5-(2',6'-dichlorobenzylidene) 6-methyl (4H)-pyridazine (PC 89).
    Pham HC; Lasserre B; Tronche P; Couquelet J; Dossou-Gbete V; Palhares de Miranda AL
    Prostaglandins Leukot Med; 1985 Jul; 19(1):37-49. PubMed ID: 3929276
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Determination of specific inhibitors of thromboxane A2 formation.
    Ladd N; Lewis GP
    Br J Pharmacol; 1980 May; 69(1):3-5. PubMed ID: 7378655
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Platelet function and biosynthesis of prostacyclin and thromboxane A2 in whole blood after aspirin administration in human subjects.
    Mehta JL; Mehta P; Lopez L; Ostrowski N; Aguila E
    J Am Coll Cardiol; 1984 Oct; 4(4):806-11. PubMed ID: 6384329
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Prostacyclin and thromboxane A2 biosynthesis capacities of heart, arteries and platelets at various stages of experimental atherosclerosis in rabbits.
    Gryglewski RJ; Dembińska-Kièć A; Zmuda A; Gryglewska T
    Atherosclerosis; 1978 Dec; 31(4):385-94. PubMed ID: 365189
    [No Abstract]   [Full Text] [Related]  

  • 12. The effect of ethanol on thromboxane synthesis by blood platelets.
    Pennington SN; Smith CP
    Prostaglandins Med; 1979 Jan; 2(1):43-50. PubMed ID: 575859
    [TBL] [Abstract][Full Text] [Related]  

  • 13. In vivo inhibition of thromboxane biosynthesis by hydralazine.
    Greenwald JE; Wong LK; Alexander M; Bianchine JR
    Adv Prostaglandin Thromboxane Res; 1980; 6():293-5. PubMed ID: 7386270
    [No Abstract]   [Full Text] [Related]  

  • 14. Role of prostacyclin and thromboxane A2 in ischaemic heart disease.
    Neri Serneri GG; Gensini GF; Masotti G; Abbate R; Morettini A; Poggesi L; Fortini A
    Adv Exp Med Biol; 1984; 164():175-85. PubMed ID: 6364706
    [No Abstract]   [Full Text] [Related]  

  • 15. Increased synthesis of thromboxane A2 by platelets from patients with Kawasaki disease.
    Hidaka T; Nakano M; Ueta T; Komatsu Y; Yamamoto M
    J Pediatr; 1983 Jan; 102(1):94-6. PubMed ID: 6401332
    [No Abstract]   [Full Text] [Related]  

  • 16. Interference of transmethylation inhibitors with thromboxane synthesis in rat platelets: evidence for the requirement of a methyl transfer reaction in platelet activation.
    Lecompte T; Randon J; Chignard M; Vargaftig BB; Dray F
    Adv Prostaglandin Thromboxane Leukot Res; 1983; 11():441-7. PubMed ID: 6221560
    [No Abstract]   [Full Text] [Related]  

  • 17. Rabbit lung microsomes: a rapid method for assaying simultaneously drug effects on thromboxane and prostacyclin synthesis.
    Ahnfelt-Rønne I; Arrigoni-Martelli E
    Agents Actions Suppl; 1979; (4):110-9. PubMed ID: 386739
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Differential inhibition by low-dose aspirin of human venous prostacyclin synthesis and platelet thromboxane synthesis.
    Hanley SP; Bevan J; Cockbill SR; Heptinstall S
    Lancet; 1981 May; 1(8227):969-71. PubMed ID: 6112387
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The enzymatic conversion of prostaglandin endoperoxides to thromboxane-A2-like activity by human iris microsomes.
    Kulkarni PS; Eakins KE
    Prostaglandins; 1977 Sep; 14(3):601-5. PubMed ID: 905583
    [No Abstract]   [Full Text] [Related]  

  • 20. Why do some beta adrenergic agonists inhibit generation of thromboxane A2 in incubates of platelets with arachidonic acid?
    Chignard M; Vargaftig BB
    Biochem Pharmacol; 1978; 27(11):1603-6. PubMed ID: 29642
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 6.